Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

210 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dose-intensified accelerated vindesine-ifosfamide-cisplatin (VIP) chemotherapy followed by high-dose accelerated hyperfractionated radiotherapy in patients with pathologically proven stage IIIB non-small cell lung cancer: a feasibility study.
De Ruysscher D, Lievens Y, Van den Brande P, Nackaerts K, Vansteenkiste J. De Ruysscher D, et al. Among authors: lievens y. Radiother Oncol. 2002 Jul;64(1):33-6. doi: 10.1016/s0167-8140(02)00144-5. Radiother Oncol. 2002. PMID: 12208572
Development and external validation of prognostic model for 2-year survival of non-small-cell lung cancer patients treated with chemoradiotherapy.
Dehing-Oberije C, Yu S, De Ruysscher D, Meersschout S, Van Beek K, Lievens Y, Van Meerbeeck J, De Neve W, Rao B, van der Weide H, Lambin P. Dehing-Oberije C, et al. Among authors: lievens y. Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):355-62. doi: 10.1016/j.ijrobp.2008.08.052. Epub 2008 Dec 25. Int J Radiat Oncol Biol Phys. 2009. PMID: 19095367
A systematic methodology review of phase I radiation dose escalation trials.
Pijls-Johannesma M, van Mastrigt G, Hahn SM, De Ruysscher D, Baumert BG, Lammering G, Buijsen J, Bentzen SM, Lievens Y, Kramar A, Lambin P. Pijls-Johannesma M, et al. Among authors: lievens y. Radiother Oncol. 2010 May;95(2):135-41. doi: 10.1016/j.radonc.2010.02.009. Epub 2010 Mar 24. Radiother Oncol. 2010. PMID: 20338652
Cardiac comorbidity is an independent risk factor for radiation-induced lung toxicity in lung cancer patients.
Nalbantov G, Kietselaer B, Vandecasteele K, Oberije C, Berbee M, Troost E, Dingemans AM, van Baardwijk A, Smits K, Dekker A, Bussink J, De Ruysscher D, Lievens Y, Lambin P. Nalbantov G, et al. Among authors: lievens y. Radiother Oncol. 2013 Oct;109(1):100-6. doi: 10.1016/j.radonc.2013.08.035. Epub 2013 Sep 14. Radiother Oncol. 2013. PMID: 24044794 Free article.
In reply to de Ruysscher et al.
Vanderstraeten B, De Neve W, Lievens Y, Verstraete J, De Croock R. Vanderstraeten B, et al. Among authors: lievens y. Int J Radiat Oncol Biol Phys. 2014 Sep 1;90(1):239. doi: 10.1016/j.ijrobp.2014.06.007. Int J Radiat Oncol Biol Phys. 2014. PMID: 25195996 No abstract available.
Highly Accelerated Irradiation in 5 Fractions (HAI-5): Feasibility in Elderly Women With Early or Locally Advanced Breast Cancer.
Monten C, Lievens Y, Olteanu LAM, Paelinck L, Speleers B, Deseyne P, Van Den Broecke R, De Neve W, Veldeman L. Monten C, et al. Among authors: lievens y. Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):922-930. doi: 10.1016/j.ijrobp.2017.01.229. Epub 2017 Feb 1. Int J Radiat Oncol Biol Phys. 2017. PMID: 28366576 Clinical Trial.
ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer.
Nestle U, De Ruysscher D, Ricardi U, Geets X, Belderbos J, Pöttgen C, Dziadiuszko R, Peeters S, Lievens Y, Hurkmans C, Slotman B, Ramella S, Faivre-Finn C, McDonald F, Manapov F, Putora PM, LePéchoux C, Van Houtte P. Nestle U, et al. Among authors: lievens y. Radiother Oncol. 2018 Apr;127(1):1-5. doi: 10.1016/j.radonc.2018.02.023. Epub 2018 Mar 28. Radiother Oncol. 2018. PMID: 29605476
210 results